General Information of the Compound
Compound ID |
CP0399340
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
6-[[2-[4-[(E)-2-(2,2-difluoro-12-thiophen-2-yl-3-aza-1-azonia-2-boranuidatricyclo[7.3.0.03,7]dodeca-1(12),4,6,8,10-pentaen-4-yl)ethenyl]phenoxy]acetyl]amino]-N-[4-[[(2S)-2-hydroxy-3-naphthalen-1-yloxypropyl]amino]butyl]hexanamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C46H50BF2N5O5S
|
||||||||||||||||||
Molecular Weight |
833.811
|
||||||||||||||||||
Canonical SMILES |
O[C@@H](CNCCCCNC(=O)CCCCCNC(=O)COc1ccc(\C=C\c2ccc3C=C4C=CC(c5cccs5)=[N+]4[B-](F)(F)n23)cc1)COc1cccc2ccccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C46H50BF2N5O5S/c48-47(49)53-36(20-21-37(53)30-38-22-25-42(54(38)47)44-14-9-29-60-44)19-16-34-17-23-40(24-18-34)58-33-46(57)52-27-5-1-2-15-45(56)51-28-7-6-26-50-31-39(55)32-59-43-13-8-11-35-10-3-4-12-41(35)43/h3-4,8-14,16-25,29-30,39,50,55H,1-2,5-7,15,26-28,31-33H2,(H,51,56)(H,52,57)/b19-16+/t39-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
VTORCSYJQIXGAT-NLOSWMTRSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor
Protein ID: PT01493, Beta-3 adrenergic receptor